The Current Study Sample Clauses

The Current Study. In the current study, we examined 9- to 12-year-old children’s comprehension of temporal relations in sentences with two successive events and temporal connec- tives. We designed a computerized self-paced reading task based on the paradigm used by Xxxxxxxxx and Xxxxxxxxx (2012) in which children read two-clause sen- tences containing the temporal connective before or after, in sentence initial or sentence medial position. This manipulation caused events to be presented either in chronological or non-chronological order (see Table 4.1). Following each sen- tence children were shown pictures of both events and were asked to indicate which of these events occurred first (Experiment 1), or last (Experiment 2) (see Figure 4.1). It should be noted that our study differed from the Xxxxxxxxx and Xxxxxxxxx study in that the current computerized task did not allow for rereading: on each trial the sentence appeared on the first screen and was then replaced by a second screen with the comprehension question. As a consequence, our task likely puts greater demands on the participants’ WM. The present task’s demands on WM are more similar to the listening task used by Xxxxxxxx and colleagues (2015) with preschool children. Our first hypothesis, in line with previous studies was that 9- to 12-year-old children would perform above chance for all sentence types, reflecting a general understanding of the temporal connectives (Blything & Xxxx, 2016; Xxxx & Xxxx, 2011; Xxxxxxxxx & Xxxxxxxxx, 2012). However, in line with previous studies we predicted that non-chronological sentences would be more difficult to process compared to chronological sentences because these sentences place greater de- mands on the reader’s limited WM resources. These difficulties should be re- flected in lower accuracy scores and longer reading times. In addition, the current study is the first that aims to explore the differential roles of WM capacity and WM updating in comprehension of complex sentences with temporal connectives by directly examining individual differences in both types of WM ability. Therefore, we included a measure of WM capacity, a Sen- tence Span task (Xxxxxxx, Xxxxxxx, & Xxxxx, 1989), which measures partici- pants’ capacity to keep words in WM while performing a second task (i.e. answering a question), and a measure of WM updating, the Mental Counters task (Xxxxxxxx et al., 2006), which measures participants’ ability to continuously up- date and monitor numerical information kep...
AutoNDA by SimpleDocs
The Current Study. The current study characterizes the longitudinal association of sleep dysfunction and positive prodromal symptoms in a large CHR sample. Studying this association in a CHR sample, which is enriched for individuals in the prodromal period preceding psychosis, will allow a better understanding of how sleep problems may contribute to worsening prodromal symptoms and/or psychotic illness. Further, utilizing data from three time points allows the opportunity to explore nuances of the longitudinal change process. Finally, the uniquely large sample size of this study also allows for more statistical power to test for bidirectional relationships between sleep and positive prodromal symptoms over time. As noted above, this has not been examined to date, and the present study will apply a rigorous test of the directionality of the relationships across time. Based on past findings, as well as theories of the adverse effects of sleep disturbance, it is predicted that problems with sleep will contribute to an increase in positive symptom severity.
The Current Study. The current study is innovative in three ways. First, we empirically test the theoretical notions of how maternal (symptoms of depression and anxiety, perceived stress, social support, sleep, and mood) and infant (temperament) characteristics are associated with perceptions of PSE cross-sectionally. Second, we take a novel approach to studying PSE by examining it as a dynamic construct. Third, we examine how changes in a subset of maternal characteristics (symptoms of depression and anxiety, positive and negative mood, and perceived stress) are related to PSE in the moment and over time, using an intensive longitudinal design. The overall aim of these latter two aspects of the study was to develop a more nuanced understanding of how maternal affective states may be associated with parenting beliefs by examining their associations in the moment and over time. As such, the current study expands on published findings in several ways. First, the majority of the reviewed studies relied on observational (lab- or home-based) measurements of parenting that involved discrete, brief amounts of time and were typically in one context (play). We add to the typical approach by taking an ecologically valid approach, using novel, mobile phone-based methodology to sample mothers’ reports of their affective states and their parenting beliefs in the moment, as they go about their everyday lives. Second, reviewed studies typically relied on correlations between (a) summary scores capturing observed parenting qualities over a discrete period of observation and (b) depression symptom levels typically measured just prior to the observations, and typically having asked women to reflect on their symptom severity levels over past week or past two-weeks. Although we attempt to expand on findings from such studies, using their same approach, in contrast to these two design features, we add to the literature by also investigating how (a) depressive and anxiety symptom levels, (b) maternal positive mood (c) maternal negative mood, and (d) maternal perceived stress in the moment are associated with PSE in the moment. Specific Aim One Examine associations between parenting self-efficacy and symptoms of depression in first time mothers of infants. Although this is a well-replicated finding, as reviewed above, we thought it was essential to test whether we would replicate this finding at baseline among women whom we further studied in terms of the dynamics of PSE and its correlates. Extend...
The Current Study 

Related to The Current Study

  • Facilities Study In analyzing and preparing the Facilities Study, and in designing and constructing the Attachment Facilities, Local Upgrades and/or Network Upgrades described in the Specifications attached to this ISA, Transmission Provider, the Interconnected Transmission Owner(s), and any other subcontractors employed by Transmission Provider have had to, and shall have to, rely on information provided by Interconnection Customer and possibly by third parties and may not have control over the accuracy of such information. Accordingly, NEITHER TRANSMISSION PROVIDER, THE INTERCONNECTED TRANSMISSION OWNER(s), NOR ANY OTHER SUBCONTRACTORS EMPLOYED BY TRANSMISSION PROVIDER OR INTERCONNECTED TRANSMISSION OWNER MAKES ANY WARRANTIES, EXPRESS OR IMPLIED, WHETHER ARISING BY OPERATION OF LAW, COURSE OF PERFORMANCE OR DEALING, CUSTOM, USAGE IN THE TRADE OR PROFESSION, OR OTHERWISE, INCLUDING WITHOUT LIMITATION IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE ACCURACY, CONTENT, OR CONCLUSIONS OF THE FACILITIES STUDY OR THE SYSTEM IMPACT STUDY IF A FACILITIES STUDY WAS NOT REQUIRED OR OF THE ATTACHMENT FACILITIES, THE LOCAL UPGRADES AND/OR THE NETWORK UPGRADES, PROVIDED, HOWEVER, that Transmission Provider warrants that the Transmission Owner Interconnection Facilities and any Merchant Transmission Upgrades described in the Specifications will be designed and constructed (to the extent that Interconnected Transmission Owner is responsible for design and construction thereof) and operated in accordance with Good Utility Practice, as such term is defined in the Operating Agreement. Interconnection Customer acknowledges that it has not relied on any representations or warranties not specifically set forth herein and that no such representations or warranties have formed the basis of its bargain hereunder.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Trials The Ship shall run the following test and trials:

  • Feasibility Study Buyer will, at Buyer's expense and within ____ days from Effective Date ("Feasibility Study Period"), determine whether the Property is suitable, in Buyer's sole and absolute discretion, for ___________________ use. During the Feasibility Study Period, Buyer may conduct a Phase I environmental assessment and any other tests, analyses, surveys and investigations ("Inspections") that Buyer deems necessary to determine to Buyer's satisfaction the Property's engineering, architectural and environmental properties; zoning and zoning restrictions; subdivision statutes; soil and grade; availability of access public roads, water, and other utilities; consistency with local, state and regional growth management plans, availability of permits, government approvals, and licenses; and other inspections that Buyer deems appropriate to determine the Property's suitability for the Buyer's intended use. If the Property must be rezoned, Buyer will obtain the rezoning from the appropriatx xxxernment agencies. Seller will sign all documents Buyer is required to file in connection with development or rezoning approvals. Seller gives Buyer, its agents, contractors and assigns, the right to enter the Property at any time during the Feasibility Study Period for the purpose of conducting inspections; provided, however, that Buyer, its agents, contractors and assigns enter the Property and conduct inspections at their own risk. Buyer will indemnify and hold Seller harmless from xxxxes, damages, costs, claims and expenses of any nature, including attorney's fees, expenses and liability incurred in application for rezoning or related proceedings, and from liability to any person, arising from the conduct of any and all inspections of any work authorized by Buyer. Buyer will not engage in any activity that xxxxx result in a construction lien being filed against the Property without Seller's prior written consent. If this transaction does not close, Buyer will, at Buyer's expense, (1) repair all damages to the Property resulting from the Inspections and return the Property to the condition it was in prior to conduct of the Inspections, and (2) release to Seller all reports and other work generated as a result of the Inspections. Buyer will deliver written notice to Seller prior to the expiration of the Feasibility Study Period of Buyer's determination of whether or not the Properxx xx acceptable. Buyer's failure to comply with this notice requirement will constitute acceptance of the Property as suitable for Buyer's intended use in its "as is" condition. If the Property is unacceptable to Buyer and written notice of this fact is timely delivered to Seller, this Contract will be deemed terminated as of the day after the Feasibility Study period ends and Buyer's deposit(s) will be returned after Escrow Axxxx receives proper authorization form all interested parties.

  • Independent Study Independent study is a program of independent study, research, and/or experience directly related to the duties described in the employee’s job description or related classification as determined by the Retraining and Study Committee, which promises professional values equivalent to that derived from formal study at a recognized educational institution.

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Statewide HUB Program Statewide Procurement Division Note: In order for State agencies and institutions of higher education (universities) to be credited for utilizing this business as a HUB, they must award payment under the Certificate/VID Number identified above. Agencies, universities and prime contractors are encouraged to verify the company’s HUB certification prior to issuing a notice of award by accessing the Internet (xxxxx://xxxxx.xxx.xxxxx.xx.xx/tpasscmblsearch/index.jsp) or by contacting the HUB Program at 000-000-0000 or toll-free in Texas at 0-000-000-0000.

  • Credit Union Examination We may disregard any information on any check or draft other than the signature of the drawer, the amount, and any magnetic encoding. You agree that we do not fail to exercise ordinary care in paying an item solely because our procedures do not provide for sight examination of items.

  • Please see the current Washtenaw Community College catalog for up-to-date program requirements Secondary / Post-Secondary Program Alignment Welding HIGH SCHOOL COURSE SEQUENCE 9th Grade 10th Grade 11th Grade 12th Grade English 9 Algebra I World History/Geography Biology World Language Phys Ed/Health English 10 Geometry U.S. History/Geography Physics or Chemistry World Language Visual/Performing/Applied Arts English 11 Algebra II Civics/Economics Welding English 12 Math Credit Science Credit Welding WASHTENAW COMMUNITY COLLEGE Welding Associate in Applied Science Semester 1 Math Elective(s)* 3 WAF 105 Introduction to Welding Processes 2 WAF 111 Oxy-fuel Welding 4 WAF 112 Shielded Metal Arc Welding 4 Semester Total 13 Semester 2 Speech Elective(s) 3 WAF 106 Blueprint Reading for Welders 3 WAF 123 Advanced Oxy-fuel Welding 4 WAF 124 Advanced Shielded Metal Arc Welding 4 Semester Total 14 Semester 3 Arts/Human. Elective(s) 3 Computer Lit. Elective(s) 3 WAF 215 Advanced Gas Tungsten Arc Welding 4 WAF 288 Gas Metal Arc Welding 4 Semester Total 14 Semester 4 WAF 200 Layout Theory Welding 3 WAF 210 Welding Metallurgy 3 Soc. Sci. Elective(s) 3 WAF 226 Specialized Welding Procedures 4 Semester Total 13 Semester 5 Nat. Sci. Elective(s) 4 WAF 227 Basic Fabrication 3 WAF 229 Shape Cutting Operations 3 Writing Elective(s) 3 Semester Total 13 Program Totals 67

Time is Money Join Law Insider Premium to draft better contracts faster.